个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
周一盘中交易时段,12只医疗保健类股走势
Gainers
- SmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday's regular session. SmileDirectClub's stock is trading at a volume of 29.4 million shares as of 12:30 EST. This is 1518.1% of its average full-day volume over the last 100 days. The company's market cap stands at $85.9 million.
- NeuroPace (NASDAQ:NPCE) stock moved upwards by 29.05% to $3.42. As of 12:30 EST, NeuroPace's stock is trading at a volume of 58.2K, which is 56.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.1 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 28.81% to $2.28. The current volume of 15.6 million shares is 1113.7% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $30.8 million.
- ATI Physical Therapy (NYSE:ATIP) shares moved upwards by 25.86% to $0.42. Trading volume for ATI Physical Therapy's stock is 2.2 million as of 12:30 EST. This is 329.2% of its average full-day volume over the last 100 days. The company's market cap stands at $87.0 million.
- Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 25.4% to $2.32. Trading volume for Galera Therapeutics's stock is 553.3K as of 12:30 EST. This is 441.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.1 million.
- Aveanna Healthcare Hldgs (NASDAQ:AVAH) shares increased by 24.75% to $1.26. As of 12:30 EST, Aveanna Healthcare Hldgs's stock is trading at a volume of 3.2 million, which is 655.6% of its average full-day volume over the last 100 days. The company's market cap stands at $234.2 million.
Losers
- Catalyst Biosciences (NASDAQ:CBIO) shares decreased by 57.2% to $0.27 during Monday's regular session. Trading volume for Catalyst Biosciences's stock is 17.8 million as of 12:30 EST. This is 4730.0% of its average full-day volume over the last 100 days. The company's market cap stands at $10.1 million.
- OKYO Pharma (NASDAQ:OKYO) stock fell 27.11% to $1.99. The market value of their outstanding shares is at $43.3 million.
- Omega Therapeutics (NASDAQ:OMGA) stock fell 24.94% to $8.22. Trading volume for Omega Therapeutics's stock is 366.5K as of 12:30 EST. This is 897.3% of its average full-day volume over the last 100 days. The company's market cap stands at $394.9 million.
- Biora Therapeutics (NASDAQ:BIOR) stock decreased by 19.44% to $4.27. Trading volume for this security as of 12:30 EST is 2.4 million, which is 127.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.1 million.
- MyMD Pharmaceuticals (NASDAQ:MYMD) shares declined by 17.75% to $1.53. As of 12:30 EST, this security is trading at a volume of 277.0K shares, making up 172.0% of its average full-day volume over the last 100 days. The company's market cap stands at $60.3 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock fell 17.56% to $0.78. As of 12:30 EST, Ensysce Biosciences's stock is trading at a volume of 1.9 million, which is 159.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.9 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- SmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday's regular session. SmileDirectClub's stock is trading at a volume of 29.4 million shares as of 12:30 EST. This is 1518.1% of its average full-day volume over the last 100 days. The company's market cap stands at $85.9 million.
- NeuroPace (NASDAQ:NPCE) stock moved upwards by 29.05% to $3.42. As of 12:30 EST, NeuroPace's stock is trading at a volume of 58.2K, which is 56.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.1 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 28.81% to $2.28. The current volume of 15.6 million shares is 1113.7% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $30.8 million.
- ATI Physical Therapy (NYSE:ATIP) shares moved upwards by 25.86% to $0.42. Trading volume for ATI Physical Therapy's stock is 2.2 million as of 12:30 EST. This is 329.2% of its average full-day volume over the last 100 days. The company's market cap stands at $87.0 million.
- Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 25.4% to $2.32. Trading volume for Galera Therapeutics's stock is 553.3K as of 12:30 EST. This is 441.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.1 million.
- Aveanna Healthcare Hldgs (NASDAQ:AVAH) shares increased by 24.75% to $1.26. As of 12:30 EST, Aveanna Healthcare Hldgs's stock is trading at a volume of 3.2 million, which is 655.6% of its average full-day volume over the last 100 days. The company's market cap stands at $234.2 million.
- 微笑直销俱乐部 纳斯达克股票代码:SDC)股价在周一的例会上上涨了47.0%,至0.71美元。截至美国东部标准时间 12:30,SmileDirectClub的股票交易量为2940万股。这是其过去 100 天平均全日交易量的1518.1%。该公司的市值为8,590万美元。
- 神经空间 纳斯达克股票代码:NPCE)的股票上涨了29.05%,至3.42美元。截至美国东部标准时间 12:30,NeuroPace的股票交易量为58.2万,占其过去100天平均全日交易量的56.5%。他们已发行股票的市值为8,510万美元。
- 航天制药 纳斯达克股票代码:SHPH)股价上涨28.81%,至2.28美元。目前的1,560万股成交量是Shuttle Pharmicals过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的1113.7%。他们已发行股票的市值为3,080万美元。
- ATI 物理疗法 纽约证券交易所代码:ATIP)股价上涨了25.86%,至0.42美元。截至美国东部标准时间 12:30,ATI Physical Therapy股票的交易量为220万股。这是其过去 100 天平均全日交易量的329.2%。该公司的市值为8,700万美元。
- 加莱拉疗法 纳斯达克股票代码:GRTX)的股票上涨了25.4%,至2.32美元。截至美国东部标准时间 12:30,Galera Therapeutics股票的交易量为553.3万。这是其过去 100 天平均全日交易量的441.8%。他们已发行股票的市值为6,610万美元。
- Aveanna 医疗控股公司 纳斯达克股票代码:AVAH)的股价上涨了24.75%,至1.26美元。截至美国东部标准时间 12:30,Aveanna Healthcare Holdgs的股票交易量为320万股,占其过去100天平均全日交易量的655.6%。该公司的市值为2.342亿美元。
Losers
失败者
- Catalyst Biosciences (NASDAQ:CBIO) shares decreased by 57.2% to $0.27 during Monday's regular session. Trading volume for Catalyst Biosciences's stock is 17.8 million as of 12:30 EST. This is 4730.0% of its average full-day volume over the last 100 days. The company's market cap stands at $10.1 million.
- OKYO Pharma (NASDAQ:OKYO) stock fell 27.11% to $1.99. The market value of their outstanding shares is at $43.3 million.
- Omega Therapeutics (NASDAQ:OMGA) stock fell 24.94% to $8.22. Trading volume for Omega Therapeutics's stock is 366.5K as of 12:30 EST. This is 897.3% of its average full-day volume over the last 100 days. The company's market cap stands at $394.9 million.
- Biora Therapeutics (NASDAQ:BIOR) stock decreased by 19.44% to $4.27. Trading volume for this security as of 12:30 EST is 2.4 million, which is 127.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.1 million.
- MyMD Pharmaceuticals (NASDAQ:MYMD) shares declined by 17.75% to $1.53. As of 12:30 EST, this security is trading at a volume of 277.0K shares, making up 172.0% of its average full-day volume over the last 100 days. The company's market cap stands at $60.3 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock fell 17.56% to $0.78. As of 12:30 EST, Ensysce Biosciences's stock is trading at a volume of 1.9 million, which is 159.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.9 million. See Also:
- 催化剂生物科学 纳斯达克股票代码:CBIO)股价在周一的例会上下跌了57.2%,至0.27美元。截至美国东部标准时间 12:30,Catalyst Biosciences股票的交易量为1780万股。这是其过去 100 天平均全日交易量的 4730.0%。该公司的市值为1010万美元。
- OKYO 制药 纳斯达克股票代码:OKYO)股价下跌27.11%,至1.99美元。他们已发行股票的市值为4,330万美元。
- 欧米茄疗法 纳斯达克股票代码:OMGA)股价下跌24.94%,至8.22美元。截至美国东部标准时间 12:30,Omega Therapeutics股票的交易量为366.5万。这是其过去 100 天平均全日交易量的897.3%。该公司的市值为3.949亿美元。
- 比奥拉疗法 纳斯达克股票代码:BIOR)的股票下跌了19.44%,至4.27美元。截至美国东部标准时间 12:30,该证券的交易量为240万,占其过去100天平均全日交易量的127.0%。他们已发行股票的市值为3,810万美元。
- myMD 制药 纳斯达克股票代码:MYMD)股价下跌17.75%,至1.53美元。截至美国东部标准时间 12:30,该证券的交易量为277.0万股,占其过去100天平均全日交易量的172.0%。该公司的市值为6,030万美元。
- 恩赛斯生物科学 纳斯达克股票代码:ENSC)股价下跌17.56%,至0.78美元。截至美国东部标准时间 12:30,Ensysce Biosciences的股票交易量为190万股,占其过去100天平均全日交易量的159.9%。该公司的市值为490万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!